CVRX · CVRx Inc. Common Stock
View on chartInsiders & Stakes
| JOHNSON & JOHNSON 10% Owner | ▼ Sell | Open Market | 4,040,861 Shares held | 11/26/2025 | View profile |
| Hykes Kevin PRES & CEO | ▼ Sell | Open Market | 284,237 Shares held | 3/2/2026 | View profile |
| OASHEIM JARED CHIEF FINANCIAL OFFICER | ▼ Sell | Open Market | 96,703 Shares held | 3/2/2026 | View profile |
| John Robert Allen Chief Revenue Officer | ▼ Sell | Open Market | 86,036 Shares held | 3/2/2026 | View profile |
| Adamson Philip B. Chief Medical Officer | ▼ Sell | Open Market | 61,578 Shares held | 3/2/2026 | View profile |
| VERRASTRO PAUL CHIEF MKTG & STRAT OFFICER | ▼ Sell | Open Market | 60,551 Shares held | 3/2/2026 | View profile |
| Binkowski Brent CHIEF OPERATING OFFICER | ▲ Buy | Open Market | 56,514 Shares held | 8/13/2026 | View profile |
| BRUHN-DING DEAN VP of Reg. Affairs and QA | ▲ Buy | Option Exercise | 54,648 Shares held | 2/8/2022 | View profile |
| Joseph P. Slattery Director | ▲ Buy | Grant | 39,365 Shares held | 6/1/2026 | View profile |
| Morrison Gregory CHIEF HUMAN RESOURCES OFFICER | ▲ Buy | Grant | 34,000 Shares held | 3/2/2026 | View profile |
| DALE MICHAEL D Chief Executive Officer | ▲ Buy | Grant | 29,005 Shares held | 6/1/2026 | View profile |
| Yared Nadim Chief Executive Officer | ▲ Buy | Option Exercise | 26,255 Shares held | 1/29/2024 | View profile |
| BRINTNALL JOHN Chief Strategy Officer and Sec | ▲ Buy | Option Exercise | 21,901 Shares held | 4/22/2022 | View profile |
| Jain Mudit K. Director | ▲ Buy | Grant | 14,370 Shares held | 6/1/2026 | View profile |
| Martha Shadan Director | ▲ Buy | Grant | 8,720 Shares held | 6/1/2026 | View profile |
| Nielsen Kirk G. Director | ▲ Buy | Grant | 8,720 Shares held | 6/1/2026 | View profile |
| Hill, Mitch C. | ▲ Buy | Grant | 8,720 Shares held | 6/1/2026 | View profile |
| Ballinger Kevin J. | ▲ Buy | Grant | 8,720 Shares held | 6/1/2026 | View profile |
| Palmer Craig E. SVP, U.S. SALES | ▲ Buy | Option Exercise | 1,229 Shares held | 3/25/2024 | View profile |
| Galle Liz VP OF GLOBAL CLINICAL RESEARCH | ▲ Buy | Option Exercise | 778 Shares held | 10/16/2023 | View profile |
| Ali Behbahani Director | ▲ Buy | Option Exercise | 316 Shares held | 12/14/2023 | View profile |
| Johnson & Johnson Innovation - JJDC, Inc. 10% Owner | ▼ Sell | Other | 0 Shares held | 9/15/2023 | View profile |
Transaction History
| Binkowski Brent | ▲ Buy | Open Market | 26,223 | $76K | 8/13/2026 |
| Binkowski Brent | ▼ Sell | Open Market | 1,309 | $3K | 8/12/2026 |
| DALE MICHAEL D | ▲ Buy | Grant | 29,005 | $0 | 6/1/2026 |
| Nielsen Kirk G. | ▲ Buy | Grant | 8,720 | $0 | 6/1/2026 |
| Jain Mudit K. | ▲ Buy | Grant | 8,720 | $0 | 6/1/2026 |
| Joseph P. Slattery | ▲ Buy | Grant | 8,720 | $0 | 6/1/2026 |
| Hill, Mitch C. | ▲ Buy | Grant | 8,720 | $0 | 6/1/2026 |
| Ballinger Kevin J. | ▲ Buy | Grant | 8,720 | $0 | 6/1/2026 |
| Martha Shadan | ▲ Buy | Grant | 8,720 | $0 | 6/1/2026 |
| Adamson Philip B. | ▼ Sell | Open Market | 1,262 | $10K | 3/2/2026 |
| Morrison Gregory | ▲ Buy | Grant | 34,000 | $0 | 3/2/2026 |
| Hykes Kevin | ▼ Sell | Open Market | 7,763 | $61K | 3/2/2026 |
| VERRASTRO PAUL | ▼ Sell | Open Market | 1,284 | $10K | 3/2/2026 |
| OASHEIM JARED | ▼ Sell | Open Market | 1,744 | $14K | 3/2/2026 |
| John Robert Allen | ▼ Sell | Open Market | 3,964 | $31K | 3/2/2026 |
| Binkowski Brent | ▲ Buy | Grant | 15,000 | $0 | 2/27/2026 |
| Adamson Philip B. | ▲ Buy | Grant | 41,000 | $0 | 2/27/2026 |
| Hykes Kevin | ▲ Buy | Grant | 159,000 | $0 | 2/27/2026 |
| VERRASTRO PAUL | ▲ Buy | Grant | 45,000 | $0 | 2/27/2026 |
| OASHEIM JARED | ▲ Buy | Grant | 61,000 | $0 | 2/27/2026 |
| John Robert Allen | ▲ Buy | Grant | 35,000 | $0 | 2/27/2026 |
| Jain Mudit K. | ▲ Buy | Open Market | 46,800 | $298K | 2/20/2026 |
| Jain Mudit K. | ▲ Buy | Open Market | 600 | $3K | 2/18/2026 |
| JOHNSON & JOHNSON | ▼ Sell | Open Market | 6,337 | $64K | 11/26/2025 |
| JOHNSON & JOHNSON | ▼ Sell | Open Market | 2,200 | $22K | 11/24/2025 |
| JOHNSON & JOHNSON | ▼ Sell | Open Market | 500 | $5K | 11/21/2025 |
| JOHNSON & JOHNSON | ▼ Sell | Open Market | 1,000 | $10K | 11/12/2025 |
| JOHNSON & JOHNSON | ▼ Sell | Open Market | 200 | $2K | 11/7/2025 |
| JOHNSON & JOHNSON | ▼ Sell | Open Market | 52,332 | $534K | 11/6/2025 |
| Binkowski Brent | ▲ Buy | Grant | 16,600 | $0 | 8/11/2025 |
| Nielsen Kirk G. | ▲ Buy | Open Market | 10,966 | $60K | 5/15/2025 |
| Nielsen Kirk G. | ▲ Buy | Open Market | 61,200 | $320K | 5/14/2025 |
| Nielsen Kirk G. | ▲ Buy | Open Market | 101,413 | $536K | 5/13/2025 |
| Jain Mudit K. | ▲ Buy | Open Market | 150 | $789 | 5/13/2025 |
| Nielsen Kirk G. | ▲ Buy | Open Market | 25,200 | $121K | 5/12/2025 |
| Jain Mudit K. | ▲ Buy | Open Market | 1,500 | $7K | 5/12/2025 |
| Hykes Kevin | ▲ Buy | Open Market | 5,000 | $24K | 5/12/2025 |
| Hykes Kevin | ▲ Buy | Grant | 98,000 | $0 | 2/28/2025 |
| John Robert Allen | ▲ Buy | Grant | 55,000 | $0 | 2/28/2025 |
| OASHEIM JARED | ▲ Buy | Grant | 22,000 | $0 | 2/28/2025 |
| Adamson Philip B. | ▲ Buy | Grant | 20,000 | $0 | 2/28/2025 |
| VERRASTRO PAUL | ▲ Buy | Grant | 16,000 | $0 | 2/28/2025 |
| VERRASTRO PAUL | ▼ Sell | Gift | 1,040 | $0 | 11/21/2024 |
| VERRASTRO PAUL | ▲ Buy | Option Exercise | 2,500 | $13K | 11/19/2024 |
| VERRASTRO PAUL | ▼ Sell | Open Market | 1,430 | $19K | 11/19/2024 |
| Joseph P. Slattery | ▲ Buy | Open Market | 3,000 | $24K | 8/15/2024 |
| Joseph P. Slattery | ▲ Buy | Open Market | 3,000 | $25K | 8/8/2024 |
| Joseph P. Slattery | ▲ Buy | Open Market | 2,500 | $23K | 8/6/2024 |
| Hykes Kevin | ▲ Buy | Open Market | 30,000 | $251K | 8/5/2024 |
| Palmer Craig E. | ▲ Buy | Option Exercise | 379 | $90 | 3/25/2024 |
| Palmer Craig E. | ▲ Buy | Option Exercise | 404 | $96 | 3/25/2024 |
| Palmer Craig E. | ▲ Buy | Option Exercise | 151 | $36 | 3/25/2024 |
| JOHNSON & JOHNSON | ▲ Buy | Option Exercise | 300 | $71 | 2/29/2024 |
| JOHNSON & JOHNSON | ▲ Buy | Option Exercise | 23 | $5 | 2/29/2024 |
| JOHNSON & JOHNSON | ▲ Buy | Option Exercise | 489 | $116 | 2/29/2024 |
| JOHNSON & JOHNSON | ▲ Buy | Option Exercise | 584 | $138 | 2/29/2024 |
| JOHNSON & JOHNSON | ▲ Buy | Option Exercise | 158 | $37 | 2/29/2024 |
| JOHNSON & JOHNSON | ▲ Buy | Option Exercise | 189 | $45 | 2/29/2024 |
| JOHNSON & JOHNSON | ▲ Buy | Option Exercise | 165 | $39 | 2/29/2024 |
| JOHNSON & JOHNSON | ▲ Buy | Option Exercise | 118 | $28 | 2/29/2024 |
| JOHNSON & JOHNSON | ▲ Buy | Option Exercise | 71 | $17 | 2/29/2024 |
| JOHNSON & JOHNSON | ▲ Buy | Option Exercise | 442 | $524 | 2/29/2024 |
| JOHNSON & JOHNSON | ▲ Buy | Option Exercise | 142 | $168 | 2/29/2024 |
| JOHNSON & JOHNSON | ▲ Buy | Option Exercise | 252 | $997 | 2/29/2024 |
| JOHNSON & JOHNSON | ▲ Buy | Option Exercise | 79 | $406 | 2/29/2024 |
| JOHNSON & JOHNSON | ▲ Buy | Option Exercise | 85 | $20 | 2/29/2024 |
| JOHNSON & JOHNSON | ▲ Buy | Option Exercise | 758 | $180 | 2/29/2024 |
| VERRASTRO PAUL | ▼ Sell | Gift | 1,650 | $0 | 2/23/2024 |
| VERRASTRO PAUL | ▼ Sell | Open Market | 2,545 | $56K | 2/20/2024 |
| VERRASTRO PAUL | ▲ Buy | Option Exercise | 5,000 | $26K | 2/20/2024 |
| JOHNSON & JOHNSON | ▼ Sell | Other | 607,725 | $96K | 2/16/2024 |
| JOHNSON & JOHNSON | ▼ Sell | Open Market | 3,725 | $96K | 2/16/2024 |
| Yared Nadim | ▲ Buy | Option Exercise | 4,055 | $961 | 1/29/2024 |
| Yared Nadim | ▲ Buy | Option Exercise | 1,945 | $461 | 1/29/2024 |
| Joseph P. Slattery | ▲ Buy | Option Exercise | 96 | $380 | 12/28/2023 |
| Joseph P. Slattery | ▲ Buy | Option Exercise | 174 | $206 | 12/28/2023 |
| Joseph P. Slattery | ▲ Buy | Option Exercise | 224 | $53 | 12/28/2023 |
| Joseph P. Slattery | ▲ Buy | Option Exercise | 1,456 | $345 | 12/28/2023 |
| Ali Behbahani | ▲ Buy | Option Exercise | 316 | $75 | 12/14/2023 |
| Galle Liz | ▲ Buy | Option Exercise | 778 | $184 | 10/16/2023 |
| OASHEIM JARED | ▲ Buy | Option Exercise | 527 | $125 | 9/18/2023 |
| OASHEIM JARED | ▲ Buy | Option Exercise | 5,335 | $21K | 9/18/2023 |
| Johnson & Johnson Innovation - JJDC, Inc. | ▼ Sell | Other | 3,495,575 | — | 9/15/2023 |
| VERRASTRO PAUL | ▼ Sell | Open Market | 628 | $12K | 8/3/2023 |
| VERRASTRO PAUL | ▼ Sell | Gift | 2,000 | $0 | 8/2/2023 |
| VERRASTRO PAUL | ▲ Buy | Option Exercise | 3,750 | $19K | 7/31/2023 |
| VERRASTRO PAUL | ▼ Sell | Open Market | 1,122 | $20K | 7/31/2023 |
| Palmer Craig E. | ▲ Buy | Option Exercise | 295 | $70 | 5/16/2023 |
| Yared Nadim | ▼ Sell | Gift | 7,080 | $0 | 1/11/2023 |
| VERRASTRO PAUL | ▼ Sell | Gift | 4,400 | $0 | 11/30/2022 |
| VERRASTRO PAUL | ▲ Buy | Option Exercise | 9,000 | $46K | 11/28/2022 |
| VERRASTRO PAUL | ▼ Sell | Open Market | 4,000 | $47K | 11/28/2022 |
| VERRASTRO PAUL | ▼ Sell | Open Market | 600 | $8K | 11/28/2022 |
| OASHEIM JARED | ▲ Buy | Option Exercise | 1,264 | $300 | 6/2/2022 |
| OASHEIM JARED | ▲ Buy | Option Exercise | 2,528 | $599 | 6/2/2022 |
| OASHEIM JARED | ▲ Buy | Option Exercise | 3,160 | $749 | 6/2/2022 |
| OASHEIM JARED | ▲ Buy | Option Exercise | 2,633 | $624 | 6/2/2022 |
| Nielsen Kirk G. | ▲ Buy | Open Market | 8,070 | $41K | 5/24/2022 |
| Nielsen Kirk G. | ▲ Buy | Open Market | 4,432 | $22K | 5/23/2022 |
| Nielsen Kirk G. | ▲ Buy | Open Market | 13,387 | $67K | 5/20/2022 |
| Nielsen Kirk G. | ▲ Buy | Open Market | 10,976 | $55K | 5/19/2022 |
| Nielsen Kirk G. | ▲ Buy | Open Market | 3,992 | $24K | 5/5/2022 |
| Nielsen Kirk G. | ▲ Buy | Open Market | 25,503 | $153K | 5/4/2022 |
| Nielsen Kirk G. | ▲ Buy | Open Market | 32,809 | $197K | 5/3/2022 |
| Nielsen Kirk G. | ▲ Buy | Open Market | 41,988 | $251K | 5/2/2022 |
| Nielsen Kirk G. | ▲ Buy | Open Market | 100 | $597 | 4/28/2022 |
| Yared Nadim | ▲ Buy | Option Exercise | 6,059 | $1K | 4/25/2022 |
| BRINTNALL JOHN | ▲ Buy | Option Exercise | 1,590 | $377 | 4/22/2022 |
| BRINTNALL JOHN | ▲ Buy | Option Exercise | 2,584 | $612 | 4/22/2022 |
| BRINTNALL JOHN | ▲ Buy | Option Exercise | 2,221 | $526 | 4/22/2022 |
| BRINTNALL JOHN | ▲ Buy | Option Exercise | 3,792 | $899 | 4/22/2022 |
| BRINTNALL JOHN | ▲ Buy | Option Exercise | 1,264 | $300 | 4/22/2022 |
| Jain Mudit K. | ▲ Buy | Open Market | 600 | $5K | 2/28/2022 |
| Nielsen Kirk G. | ▲ Buy | Open Market | 3,400 | $28K | 2/24/2022 |
| Nielsen Kirk G. | ▲ Buy | Open Market | 38,200 | $307K | 2/23/2022 |
| Nielsen Kirk G. | ▲ Buy | Open Market | 40,008 | $318K | 2/22/2022 |
| Nielsen Kirk G. | ▲ Buy | Open Market | 26,659 | $211K | 2/18/2022 |
| BRUHN-DING DEAN | ▲ Buy | Option Exercise | 780 | $185 | 2/8/2022 |
| BRUHN-DING DEAN | ▲ Buy | Option Exercise | 12,383 | $3K | 2/8/2022 |
| BRUHN-DING DEAN | ▲ Buy | Option Exercise | 2,862 | $678 | 2/8/2022 |
| BRUHN-DING DEAN | ▲ Buy | Option Exercise | 1,264 | $300 | 2/8/2022 |
| BRUHN-DING DEAN | ▲ Buy | Option Exercise | 1,264 | $300 | 2/8/2022 |
| BRUHN-DING DEAN | ▲ Buy | Option Exercise | 2,528 | $599 | 2/8/2022 |
| BRUHN-DING DEAN | ▲ Buy | Option Exercise | 1,169 | $277 | 2/8/2022 |
| BRUHN-DING DEAN | ▲ Buy | Option Exercise | 821 | $195 | 2/8/2022 |
| BRUHN-DING DEAN | ▲ Buy | Option Exercise | 378 | $90 | 2/8/2022 |
| BRUHN-DING DEAN | ▲ Buy | Option Exercise | 1,590 | $377 | 2/8/2022 |
| BRUHN-DING DEAN | ▲ Buy | Option Exercise | 2,528 | $599 | 2/8/2022 |
| BRUHN-DING DEAN | ▲ Buy | Option Exercise | 2,275 | $539 | 2/8/2022 |
| BRUHN-DING DEAN | ▲ Buy | Option Exercise | 5,158 | $1K | 2/8/2022 |
| Yared Nadim | ▲ Buy | Option Exercise | 2,659 | $630 | 2/3/2022 |
| Yared Nadim | ▲ Buy | Option Exercise | 5,057 | $1K | 2/3/2022 |
| Yared Nadim | ▲ Buy | Option Exercise | 3,792 | $899 | 2/3/2022 |
| Yared Nadim | ▲ Buy | Option Exercise | 5,916 | $1K | 2/3/2022 |
| Yared Nadim | ▲ Buy | Option Exercise | 1,266 | $300 | 2/3/2022 |
| Yared Nadim | ▼ Sell | Gift | 10,500 | $0 | 1/19/2022 |
| Joseph P. Slattery | ▲ Buy | Option Exercise | 2,149 | $509 | 1/13/2022 |
| Joseph P. Slattery | ▲ Buy | Option Exercise | 3,917 | $928 | 1/13/2022 |
| Joseph P. Slattery | ▲ Buy | Option Exercise | 316 | $75 | 1/13/2022 |
| Joseph P. Slattery | ▲ Buy | Option Exercise | 316 | $75 | 1/13/2022 |
| Joseph P. Slattery | ▲ Buy | Option Exercise | 2,528 | $599 | 1/13/2022 |
| Joseph P. Slattery | ▲ Buy | Option Exercise | 189 | $45 | 1/13/2022 |
| Joseph P. Slattery | ▲ Buy | Option Exercise | 189 | $45 | 1/13/2022 |
| Joseph P. Slattery | ▲ Buy | Option Exercise | 189 | $45 | 1/13/2022 |
| Joseph P. Slattery | ▲ Buy | Option Exercise | 189 | $45 | 1/13/2022 |
| Joseph P. Slattery | ▲ Buy | Option Exercise | 316 | $75 | 1/13/2022 |
| Joseph P. Slattery | ▲ Buy | Option Exercise | 758 | $180 | 1/13/2022 |
| Joseph P. Slattery | ▲ Buy | Option Exercise | 584 | $693 | 1/13/2022 |
| BRINTNALL JOHN | ▲ Buy | Option Exercise | 2,550 | $604 | 12/30/2021 |
| Yared Nadim | ▲ Buy | Option Exercise | 2,080 | $493 | 12/28/2021 |
| Joseph P. Slattery | ▲ Buy | Option Exercise | 3,000 | $720 | 11/30/2021 |
| BRUHN-DING DEAN | ▲ Buy | Option Exercise | 14,000 | $3K | 11/24/2021 |
| Yared Nadim | ▲ Buy | Option Exercise | 11,006 | $3K | 11/22/2021 |
| Jain Mudit K. | ▲ Buy | Open Market | 300 | $4K | 11/19/2021 |
| Jain Mudit K. | ▲ Buy | Open Market | 875 | $13K | 11/18/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
CVRx Appoints John Landry as CFO
CVRx announced that John Landry will become chief financial officer, effective Oct. 12, replacing Jared Oasheim. The change follows a routine leadership transition and may bring new financial oversight to the company. The appointment is noted by market watchers but does not alter the current trading range or technical signals. Investors can monitor how the new CFO’s approach aligns with the company’s financial goals.
CVRx Appoints John Landry as CFO. CVRx announced that John Landry will become chief financial officer, effective Oct. 12, replacing Jared Oasheim. The change follows a routine leadership transition and may bring new financial oversight to the company. The appointment is noted by market watchers but does not alter the current trading range or technical signals. Investors can monitor how the new CFO’s approach aligns with the company’s financial goals.